(Q45187443)

10 December 2017

Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques (English)

1 reference

10 December 2017

0 references

9

1 reference

10 December 2017

10

Peter A Barry

1 reference

10 December 2017

Yujuan Yue

1

1 reference

10 December 2017

Zhongde Wang

2

1 reference

10 December 2017

Kristina Abel

3

1 reference

10 December 2017

Jinliang Li

4

1 reference

10 December 2017

Lisa Strelow

5

1 reference

10 December 2017

Angelo Mandarino

6

1 reference

10 December 2017

Meghan K Eberhardt

7

1 reference

10 December 2017

Kimberli A Schmidt

8

1 reference

10 December 2017

15 January 2008

1 reference

Medical Microbiology and Immunology

10 December 2017

1 reference

10 December 2017

197

1 reference

10 December 2017

2

1 reference

10 December 2017

117-123

1 reference

https://scigraph.springernature.com/pub.10.1007/s00430-008-0074-5

10 December 2017

0 references

cites work

Nonhuman primate models of intrauterine cytomegalovirus infection

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00430-008-0074-5

The outcome of congenital cytomegalovirus infection in relation to maternal antibody status

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00430-008-0074-5

Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine

21 January 2018

1 reference

12 December 2020

A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant

1 reference

12 December 2020

Differential detection of B virus and rhesus cytomegalovirus in rhesus macaques

1 reference

12 December 2020

Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques

1 reference

12 December 2020

A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).

1 reference

12 December 2020

Preclinical evaluation of an ALVAC (canarypox)--human cytomegalovirus glycoprotein B vaccine candidate

1 reference

12 December 2020

Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine

1 reference

12 December 2020

A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques

1 reference

12 December 2020

Flow cytometric analysis of virus-specific T lymphocytes: practicability of detection of HCMV-specific T lymphocytes in whole blood in patients after stem cell transplantation

1 reference

12 December 2020

Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65).

1 reference

12 December 2020

Prevention of transfusion-acquired cytomegalovirus infections in newborn infants

1 reference

12 December 2020

Complete sequence and genomic analysis of rhesus cytomegalovirus

1 reference

12 December 2020

Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.

1 reference

12 December 2020

Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

1 reference

12 December 2020

Cytomegalovirus and simian immunodeficiency virus coinfection: longitudinal study of antibody responses and disease progression

1 reference

12 December 2020

Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.

1 reference

12 December 2020

Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus

1 reference

12 December 2020

Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.

1 reference

12 December 2020

Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques

1 reference

12 December 2020

Maternal immunity and prevention of congenital cytomegalovirus infection

1 reference

12 December 2020

Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection

1 reference

12 December 2020

Vaccine strategies against human cytomegalovirus infection.

1 reference

12 December 2020

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

1 reference

12 December 2020

Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.

1 reference

12 December 2020

10.1007/S00430-008-0074-5

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

0 references

1 reference